期刊论文详细信息
Journal of Nuclear Medicine
Whole-Body Biodistribution and Radiation Dosimetry of 18F-FP-(+)-DTBZ (18F-AV-133): A Novel Vesicular Monoamine Transporter 2 Imaging Agent
Hsiu-Ping Chang1  Daniel Skovronsky1  Shiaw-Pyng Wey1  Tzu-Chen Yen1  Yi-Hsin Weng1  Ing-Tsung Hsiao1  Chin-Song Lu1  Kun-Ju Lin1  Mei-Ping Kung1 
关键词: vesicular monoamine transporter 2;    whole-body biodistribution;    dosimetry;    PET;    Parkinson disease;   
DOI  :  10.2967/jnumed.110.078196
学科分类:医学(综合)
来源: Society of Nuclear Medicine
PDF
【 摘 要 】

Vesicular monoamine transporter 2 (VMAT2) is highly expressed in the endocrine cells and brain. We investigated the biodistribution and radiation dosimetry of (2R,3R,11bR)-9-(3-18F-fluoropropoxy)-3-isobutyl-10-methoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1-a]isoquinolin-2-ol (18F-FP-(+)-dihydrotetrabenazine [DTBZ] or 18F-AV-133), a potential VMAT2 imaging agent showing encouraging results in humans, to facilitate its future clinical use. Methods: Nine healthy human subjects (mean age ± SD, 58.6 ± 4.2 y) were enrolled for the whole-body PET scan. Serial images were acquired for 3 h immediately after a bolus injection of 390.7 ± 22.9 MBq of 18F-AV-133 per individual. The source organs were delineated on PET/CT images. The OLINDA/EXM application was used to determine the equivalent dose for individual organs. Results: The radiotracer did not show any noticeable adverse effects for the 9 subjects examined. The radioactivity uptake in the brain was the highest at 7.5% ± 0.6% injected dose at 10 min after injection. High absorbed doses were found in the pancreas, liver, and upper large intestine wall. The highest-dosed organ, which received 153.3 ± 23.8 μGy/MBq, was the pancreas. The effective dose equivalent and effective dose for 18F-AV-133 were 36.5 ± 2.8 and 27.8 ± 2.5 μSv/MBq, respectively. These values are comparable to those reported for any other 18F-labeled radiopharmaceutical. Conclusion: 18F-AV-133 is safe, with appropriate biodistribution and radiation dosimetry for imaging VMAT2 sites in humans.

【 授权许可】

Unknown   

【 预 览 】
附件列表
Files Size Format View
RO201912010197869ZK.pdf 1454KB PDF download
  文献评价指标  
  下载次数:15次 浏览次数:24次